N-power Medicine

This study does not test a new treatment. Instead, it collects information from 550 adults with advanced or metastatic non-small cell lung cancer who have already had chemotherapy. The goal is to create control arms using real-world data, which can help future trials compare trea…

This study is not testing a new drug. Instead, it follows about 130 people with advanced EGFR-mutant non-small cell lung cancer who are starting standard treatment with osimertinib. Researchers will collect detailed information on how long the treatment controls the cancer and ho…